Depigmentation therapy is considered in patients with wide-spread vitiligo (>50% body surface area, BSA), especially if in exposed sites and those who have significant cosmetic disfigurement due to residual pigmentations.… Click to show full abstract
Depigmentation therapy is considered in patients with wide-spread vitiligo (>50% body surface area, BSA), especially if in exposed sites and those who have significant cosmetic disfigurement due to residual pigmentations. Remaining pigmented patches can be removed using depigmentation creams (20-40% monobenzyl ether of hydroquinone; MBEH), laser therapy or cryotherapy[1].
               
Click one of the above tabs to view related content.